Novel chromosomal insertions of ISEcp1-bla

Anti-Bacterial Agents / pharmacology Chromosomes, Bacterial / genetics Drug Resistance, Bacterial / genetics Enterobacter cloacae / drug effects Escherichia coli / drug effects Humans Microbial Sensitivity Tests Mutagenesis, Insertional Plasmids Whole Genome Sequencing Zambia beta-Lactamases / genetics
AMR Chromosomal insertion Enterobacter cloacae Escherichia coli Extended spectrum β-lactamase ISEcp1 Zambia bla CTX-M

Journal

Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411

Informations de publication

Date de publication:
10 05 2021
Historique:
received: 15 12 2020
accepted: 21 04 2021
entrez: 11 5 2021
pubmed: 12 5 2021
medline: 17 12 2021
Statut: epublish

Résumé

The epidemiology of extended-spectrum β-lactamases (ESBLs) has undergone dramatic changes, with CTX-M-type enzymes prevailing over other types. bla A total of 46 clinical isolates of cefotaxime-resistant Enterobacteriaceae (1 Enterobacter cloacae, 9 Klebsiella pneumoniae, and 36 Escherichia coli) from Zambia were subjected to whole-genome sequencing (WGS) using MiSeq and MinION. By reconstructing nearly complete genomes, bla WGS-based genotyping identified 58 AMR genes, including four bla Our study revealed the co-occurrence of ISEcp1-bla

Sections du résumé

BACKGROUND
The epidemiology of extended-spectrum β-lactamases (ESBLs) has undergone dramatic changes, with CTX-M-type enzymes prevailing over other types. bla
METHODS
A total of 46 clinical isolates of cefotaxime-resistant Enterobacteriaceae (1 Enterobacter cloacae, 9 Klebsiella pneumoniae, and 36 Escherichia coli) from Zambia were subjected to whole-genome sequencing (WGS) using MiSeq and MinION. By reconstructing nearly complete genomes, bla
RESULTS
WGS-based genotyping identified 58 AMR genes, including four bla
CONCLUSION
Our study revealed the co-occurrence of ISEcp1-bla

Identifiants

DOI: 10.1186/s13756-021-00941-8 PMID: 33971966 PMC: PMC8111917
pubmed: 33971966
doi: 10.1186/s13756-021-00941-8
pii: 10.1186/s13756-021-00941-8
pmc: PMC8111917
doi:

Substances chimiques

Anti-Bacterial Agents 0
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

79

Références

BMC Infect Dis. 2017 Feb 2;17(1):117
pubmed: 28152988
J Antimicrob Chemother. 2017 Aug 1;72(8):2145-2155
pubmed: 28541467
Crit Rev Microbiol. 2013 Feb;39(1):79-101
pubmed: 22697133
Enferm Infecc Microbiol Clin. 2011 Dec;29(10):731-4
pubmed: 22019175
Nature. 1982 Nov 18;300(5889):278-81
pubmed: 6755263
J Antimicrob Chemother. 2012 Nov;67(11):2612-20
pubmed: 22843833
BMC Public Health. 2016 Aug 22;16:724
pubmed: 27545670
mSystems. 2020 Sep 29;5(5):
pubmed: 32994286
Antimicrob Agents Chemother. 2003 Feb;47(2):827-9
pubmed: 12543704
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Int J Genomics. 2018 Dec 20;2018:4989602
pubmed: 30671441
BMC Res Notes. 2018 Aug 31;11(1):629
pubmed: 30170613
J Infect Dev Ctries. 2010 Nov 24;4(11):717-22
pubmed: 21252449
PLoS One. 2020 Feb 10;15(2):e0228555
pubmed: 32040513
BMC Microbiol. 2015 Jun 17;15:122
pubmed: 26077154
mSphere. 2018 Nov 7;3(6):
pubmed: 30404930
Int J Infect Dis. 2020 Feb;91:207-209
pubmed: 31770618
Nat Commun. 2014 Oct 10;5:5208
pubmed: 25302567
Microb Genom. 2016 Jul 11;2(7):e000064
pubmed: 28348859
Front Microbiol. 2012 Oct 08;3:349
pubmed: 23087676
Antimicrob Resist Infect Control. 2019 Oct 31;8:169
pubmed: 31695911
Bioinformatics. 2010 Sep 15;26(18):2334-5
pubmed: 20624783
BMC Microbiol. 2019 Mar 12;19(1):59
pubmed: 30866820
Microb Genom. 2018 Jun;4(6):
pubmed: 29932391
Clin Microbiol Rev. 2013 Oct;26(4):744-58
pubmed: 24092853
PLoS One. 2017 Feb 28;12(2):e0172652
pubmed: 28245252
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
BMC Infect Dis. 2016 Jul 11;16:326
pubmed: 27400864
Microbiol Spectr. 2017 Sep;5(5):
pubmed: 28944751
Expert Rev Anti Infect Ther. 2016 Dec;14(12):1215-1223
pubmed: 27548801
J Antimicrob Chemother. 2011 Jan;66(1):1-14
pubmed: 21081548
J Antimicrob Chemother. 2018 May 1;73(5):1121-1137
pubmed: 29370371
Lancet Glob Health. 2017 May;5(5):e491-e500
pubmed: 28395844
Clin Microbiol Infect. 2014 May;20(5):380-90
pubmed: 24766445
Clin Infect Dis. 2009 Sep 1;49(5):682-90
pubmed: 19622043
Genome Biol. 2014;15(11):524
pubmed: 25410596
J Antimicrob Chemother. 2008 Feb;61(2):273-81
pubmed: 18077311
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:117-23
pubmed: 18154535
Clin Infect Dis. 2005 May 1;40(9):1333-41
pubmed: 15825037
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Bacteriol Rev. 1976 Mar;40(1):168-89
pubmed: 1267736
J Antimicrob Chemother. 2008 Nov;62(5):1153-5
pubmed: 18779257
Genome Res. 2017 May;27(5):722-736
pubmed: 28298431
J Antimicrob Chemother. 2016 May;71(5):1178-82
pubmed: 26803720
Infect Genet Evol. 2019 Sep;73:126-131
pubmed: 31029792
Antimicrob Agents Chemother. 2009 May;53(5):1808-16
pubmed: 19273688
S Afr Med J. 2004 Jun;94(6):440-2
pubmed: 15250455
Microb Genom. 2020 Apr;6(4):
pubmed: 32160146
J Infect Dis. 1999 Dec;180(6):1809-18
pubmed: 10558935
Nat Commun. 2019 Mar 8;10(1):1124
pubmed: 30850636
Clin Microbiol Rev. 2005 Oct;18(4):657-86
pubmed: 16223952
Malays J Pathol. 2016 Dec;38(3):241-249
pubmed: 28028294
J Antimicrob Chemother. 2008 Dec;62(6):1241-4
pubmed: 18779256
Antimicrob Agents Chemother. 2014 Jul;58(7):3895-903
pubmed: 24777092
Bioinformatics. 2018 Mar 15;34(6):1037-1039
pubmed: 29106469
Front Microbiol. 2015 Apr 21;6:335
pubmed: 25954262
Int J Antimicrob Agents. 2014 Jun;43(6):553-7
pubmed: 24816185
Appl Environ Microbiol. 2012 Mar;78(6):2056-8
pubmed: 22247146
J Hosp Infect. 2018 Mar;98(3):247-252
pubmed: 29222035
Genome Res. 2004 Jul;14(7):1394-403
pubmed: 15231754
Antimicrob Agents Chemother. 2012 Feb;56(2):1093-6
pubmed: 22106217
PLoS One. 2017 Jan 31;12(1):e0171216
pubmed: 28141845
Appl Environ Microbiol. 2011 Jul;77(13):4486-93
pubmed: 21602382
Afr J Lab Med. 2018 Dec 06;7(2):796
pubmed: 30568902
Evol Appl. 2015 Mar;8(3):284-95
pubmed: 25861386
PLoS One. 2014 Nov 19;9(11):e112963
pubmed: 25409509
Antimicrob Agents Chemother. 2019 Oct 22;63(11):
pubmed: 31427293
Bioinformatics. 2007 Apr 15;23(8):1026-8
pubmed: 17309896
J Clin Microbiol. 2012 Apr;50(4):1355-61
pubmed: 22238442
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4237-43
pubmed: 27139486

Auteurs

Misheck Shawa (M)

Division of Infection and Immunity, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.

Yoshikazu Furuta (Y)

Division of Infection and Immunity, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.

Gillan Mulenga (G)

Department of Pathology and Microbiology, University Teaching Hospital, Lusaka, Zambia.

Maron Mubanga (M)

Department of Para-Clinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia.

Evans Mulenga (E)

Department of Para-Clinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia.

Tuvshinzaya Zorigt (T)

Division of Infection and Immunity, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.

Christone Kaile (C)

Department of Pathology and Microbiology, University Teaching Hospital, Lusaka, Zambia.

Manyando Simbotwe (M)

Department of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia.

Atmika Paudel (A)

Division of Infection and Immunity, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.

Bernard Hang'ombe (B)

Department of Para-Clinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia.

Hideaki Higashi (H)

Division of Infection and Immunity, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan. hidea-hi@czc.hokudai.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Novel chromosomal insertions of ISEcp1-bla
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Chromosomes › Chromosomes de bactérie › Novel chromosomal insertions of ISEcp1-bla
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Novel chromosomal insertions of ISEcp1-bla
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Enterobacter › Enterobacter cloacae › Novel chromosomal insertions of ISEcp1-bla
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Escherichia › Escherichia coli › Novel chromosomal insertions of ISEcp1-bla
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Novel chromosomal insertions of ISEcp1-bla
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Novel chromosomal insertions of ISEcp1-bla
questionsmedicales.fr › Phénomènes génétiques › Mutagenèse › Mutagenèse par insertion › Novel chromosomal insertions of ISEcp1-bla
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Plasmides › Novel chromosomal insertions of ISEcp1-bla
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Séquençage du génome entier › Novel chromosomal insertions of ISEcp1-bla
questionsmedicales.fr › Régions géographiques › Afrique › Afrique subsaharienne › Afrique australe › Zambie › Novel chromosomal insertions of ISEcp1-bla
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Amidohydrolases › bêta-Lactamases › Novel chromosomal insertions of ISEcp1-bla